Related Experiment Video
Updated: Jul 9, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1
Craig M Forester1, Jessica Maddox, Justin V Louis
1Department of Oncological Sciences and Center for Children, Huntsman Cancer Institute, Salt Lake City, UT 84112, USA.
Abstract:
Inactivation of maturation-promoting factor [(MPF) Cdk1/Cyclin B] is a key event in the exit from mitosis. Although degradation of Cyclin B is important for MPF inactivation, recent studies indicate that Cdk1 phosphorylation and inactivation occur before Cyclin B degradation and, therefore, also may be important steps in the exit from mitosis. Cdk1 activity is controlled by the Cdc25C phosphatase, which is turned on at the G(2)/M transition to catalyze Cdk1 activation. PP2A:B56delta is a negative regulator of Cdc25C during interphase. We show here that PP2A:B56delta also regulates Cdc25C at mitosis. Failure of PP2A:B56delta to dephosphorylate Cdc25C at mitosis results in prolonged hyperphosphorylation and activation of Cdc25C, causing persistent dephosphorylation and, hence, activation of Cdk1. This constitutive activation of Cdc25C and Cdk1 leads to a delayed exit from mitosis. Consistent with Cdk1 as a major biological target of B56delta, stable knockdown and germ-line mouse KO of B56delta leads to compensatory transcriptional up-regulation of Wee1 kinase to oppose the Cdc25C activity and permit cell survival. These observations place PP2A:B56delta as a key upstream regulator of Cdk1 activity upon exit from mitosis.
Insights
PP2A:B56delta regulates Cdc25C phosphatase activity, controlling Cdk1 inactivation for mitotic exit. Its failure causes delayed mitosis exit, highlighting its role in cell cycle regulation.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Maturation-promoting factor (MPF) inactivation, involving Cdk1/Cyclin B, is crucial for mitotic exit.
- While Cyclin B degradation is key, Cdk1 inactivation precedes it, suggesting other regulatory mechanisms are involved.
- Cdc25C phosphatase activates Cdk1 at the G2/M transition, and PP2A:B56delta deactivates Cdc25C during interphase.
Purpose of the Study:
- To investigate the role of PP2A:B56delta in regulating Cdc25C activity during mitosis.
- To determine the impact of PP2A:B56delta dysfunction on Cdk1 activity and mitotic exit.
- To elucidate the upstream regulatory role of PP2A:B56delta in controlling Cdk1 activity during the cell cycle.
Main Methods:
- Studied PP2A:B56delta regulation of Cdc25C during mitosis.
- Utilized stable knockdown and germ-line mouse knockout (KO) of B56delta.
- Assessed Cdk1 activity, Cdc25C phosphorylation, and Wee1 kinase expression.
Main Results:
- PP2A:B56delta dephosphorylates Cdc25C at mitosis.
- Failure of PP2A:B56delta leads to sustained Cdc25C and Cdk1 activation, delaying mitotic exit.
- B56delta deficiency induces compensatory Wee1 kinase upregulation for cell survival.
Conclusions:
- PP2A:B56delta is a critical negative regulator of Cdc25C during mitosis.
- Dysfunctional PP2A:B56delta disrupts Cdk1 inactivation, causing delayed mitotic progression.
- PP2A:B56delta acts as a key upstream regulator of Cdk1 activity upon exit from mitosis.
More Related Videos
Related Concept Videos
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Anaphase Promoting Complex

